Coronary thrombolysis

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
To determine whether the administration of erythropoietin (EPO) early after the onset of ischemia could enhance the preservation… (More)
Is this relevant?
1995
1995
OBJECTIVES This study sought to assess the long-term clinical consequences of reocclusion after coronary thrombolysis… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
Review
1992
Review
1992
Although the benefits of coronary thrombolysis are well established, the optimal therapeutic strategy for ensuring rapid and… (More)
Is this relevant?
1992
1992
Excessive bleeding is a major concern during the administration of thrombolytic therapy. Although the great majority of these… (More)
  • figure 2
  • figure 1
Is this relevant?
1990
1990
Tissue plasminogen activator (tPA), an approved coronary thrombolytic agent, can cause serious bleeding. We report the cases of… (More)
Is this relevant?
1989
1989
Platelet activation is markedly increased during coronary thrombolysis and limits the response to thrombolytic therapy. A… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Dilation of the left ventricle after myocardial infarction is common, occurs rapidly (within 2 weeks of infarction) and may be… (More)
Is this relevant?
1988
1988
The long-term prognosis after thrombolytic therapy in patients with acute myocardial infarction (AMI) is unknown. This question… (More)
Is this relevant?
1987
1987
Thirty-four patients with acute myocardial infarction were treated prospectively using a new strategy of prehospital intravenous… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
1986
1986
A 53-year-old man with occlusion of the proximal left anterior descending coronary artery received intravenous tissue plasminogen… (More)
Is this relevant?